- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by ViiV
Total 363 results
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States, Spain, France, United Kingdom, Chile, Brazil, Italy, Portugal
-
ViiV HealthcarePfizerCompleted
-
ViiV HealthcareShionogiCompletedInfections, Human Immunodeficiency Virus and HepatitisUnited States
-
ViiV HealthcarePfizerCompletedHuman Immunodeficiency Virus-1United States, Spain, Germany
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV-1 Infection | Infection, Human Immunodeficiency Virus IGermany, Spain, France, Belgium, United Kingdom, Italy, Romania, Russian Federation, Switzerland
-
ViiV HealthcarePfizerCompletedHIV InfectionsNetherlands, United States, Italy, Spain, United Kingdom, France, Germany, Australia, Switzerland, Belgium, Canada, Poland, Sweden
-
ViiV HealthcarePfizerCompleted
-
ViiV HealthcarePfizerCompleted
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infection | Cardiovascular Disease | Acute Myocardial Infarction | Infection, Human Immunodeficiency Virus
-
ViiV HealthcarePfizerCompleted
-
ViiV HealthcareGlaxoSmithKlineNot yet recruiting
-
ViiV HealthcareGlaxoSmithKlineNot yet recruitingHIV InfectionsUnited States, Canada, Spain, Italy, Argentina, Mexico
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States, France, Spain, United Kingdom, Canada, Thailand, Italy, Portugal, Russian Federation, Mexico, Argentina, South Africa, Puerto Rico
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States, Argentina, Spain, Germany, Belgium, Australia, Canada, United Kingdom, Italy, Romania, Taiwan, Russian Federation, Mexico, France, Switzerland, Peru, Poland, Portugal
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV InfectionsArgentina, Thailand, Russian Federation, Mexico, South Africa, Romania, China, Chile, Ukraine, Colombia, Peru, Brazil, Kenya
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineTerminatedHIV Infections | Infection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency Virus IUnited States, Canada, Puerto Rico
-
ViiV HealthcareGlaxoSmithKlineTerminatedHIV InfectionsUnited States, Taiwan, Peru, Canada, Thailand, Australia, Puerto Rico, Russian Federation, Argentina, Mexico, Colombia, South Africa, Chile
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusGermany
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusSpain, France, Germany
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited Kingdom
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus IUnited States, Spain, Canada, Russian Federation, Romania, Belgium, South Africa
-
ViiV HealthcareGlaxoSmithKlineCompletedInfections, Human Immunodeficiency Virus and HerpesviridaeUnited States
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKlineCompletedEffect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy SubjectsInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcarePfizerCompleted
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKlineCompletedInfections, Human Immunodeficiency Virus and Herpesviridae
-
ViiV HealthcarePfizerCompletedHealthyUnited States